In addition to highlighting the unique interest of using soluble ligands, here CXCL12, as potentially valuable drug targets (Attwood et al., 2020), the results underline the importance of the CXCL12/CXCR4 axis in lupus pathophysiology. Here, CXCR4 is linked to systemic lupus erythematosus.